Lung Cancer
Volume 65, Issue 2 , Pages 192-197, August 2009

Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m2 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

  • Mark J. McKeage

      Affiliations

    • Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, The University of Auckland, 85 Park Rd, Grafton, Private Bag 92019, Auckland 1142, New Zealand
    • Corresponding Author InformationCorresponding author. Tel.: +64 9 3737 599x87322; fax: +64 9 3737 556.
    • ,
  • Martin Reck

      Affiliations

    • Krankenhaus Grosshansdorf, Woehrendamm 80, D-22927 Grosshansdorf, Germany
    • ,
  • Michael B. Jameson

      Affiliations

    • Waikato Hospital, Private Bag 3200, Hamilton, New Zealand
    • ,
  • Mark A. Rosenthal

      Affiliations

    • Royal Melbourne Hospital, Melbourne 3050, Australia
    • ,
  • David Gibbs

      Affiliations

    • Christchurch Hospital, Private Bag 4710, Christchurch, New Zealand
    • ,
  • Paul N. Mainwaring

      Affiliations

    • Mater Health Services, Brisbane, QLD 4101, Australia
    • ,
  • Lutz Freitag

      Affiliations

    • Lungenklinik Hemer, Theo-Funccius-Str. 1, D-58675 Hemer, Germany
    • ,
  • Richard Sullivan

      Affiliations

    • Auckland City Hospital, 2 Park Road, Grafton, Auckland 1023, New Zealand
    • ,
  • Joachim Von Pawel

      Affiliations

    • Asklepios Fachkliniken, Robert-Koch-Allee 2, D-82131 Gauting, Germany

Received 15 January 2009; received in revised form 26 March 2009; accepted 28 March 2009. published online 01 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(09)00206-2

doi:10.1016/j.lungcan.2009.03.027

Lung Cancer
Volume 65, Issue 2 , Pages 192-197, August 2009

Article Tools

* Image Usage & Resolution